A man and a horse and a journey from Spain to China.
Xu Zhixian thought the trip would take about a year. After six months he’s made it from Spain to the Netherlands, about a quarter of the way. | learn more
Xu Zhixian thought the trip would take about a year. After six months he’s made it from Spain to the Netherlands, about a quarter of the way. | learn more
It starts with the cube shapes in the corner, called Finder Patterns. The most interesting part to me is the mask, of which there are 8 standard patterns. | learn more
I’m planning to try this next time I need a ride somewhere. “Users can hail an autonomous ride using the Lyft app, similarly to how they would hail a regular Lyft car. Prices for the rides will also be the same as normal Lyft rides.” | learn more
“In 2006 Byron Deeter met the team and test-drove a roadster. He put a deposit on the car, but passed on the negative margin company telling his partners, "It’s a win-win. I get a great car and some other VC pays for it!” The company passed $30B in market cap in 2014. Byron paid full price for his Model X.“ | learn more
This Paul Graham essay is partly him patting himself on the back for YC’s success. But it’s also partly a window into the recurring problems that founders face and the way his team tries to help. | learn more
“Social determinants of health (SDOH) are non-medical factors that influence health outcomes and health inequities and include the conditions in which people live, learn, work and play.” | learn more
“There are 98 active Amazon aggregators. 58 aggregators have announced funding rounds, of which 33 raised at least $100 million.” It’s only a matter of time until someone aggregates the aggregators. | learn more
“[Researchers] in the Netherlands came together to create a four-terminal perovskite/silicon tandem device. A tandem device can better use solar spectrum since it uses a mix of silicon-based solar cells with perovskite-based solar cells.” | learn more
Big Alzheimer’s disease news this week: positive results for an anti-amyloid therapy. Researcher Derek Lowe takes a more sober view: “As the world knows, the anti-amyloid clinical landscape for Alzheimer’s is absolutely littered with failures in every direction: anti-amyloid antibodies of various types, attempts to inhibit beta-secretase and gamma-secretase enzymes, attempts to prevent aggregation, you name it. Nothing has worked.” | learn more
“A whopping 19 out of 20 principals were replaced in the Houston experiment. It took over 300 interviews to find 19 principals to replace them. Of the teachers, 46% were replaced.” | learn more